144 related articles for article (PubMed ID: 14676131)
1. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.
Kim IY; Lee DH; Lee DK; Kim BC; Kim HT; Leach FS; Linehan WM; Morton RA; Kim SJ
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6046-51. PubMed ID: 14676131
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins and growth and differentiation factors in the human cornea.
You L; Kruse FE; Pohl J; Völcker HE
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):296-311. PubMed ID: 9950587
[TBL] [Abstract][Full Text] [Related]
3. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
Kim IY; Lee DH; Lee DK; Kim WJ; Kim MM; Morton RA; Lerner SP; Kim SJ
Cancer Res; 2004 Oct; 64(20):7355-60. PubMed ID: 15492256
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells.
Kim IY; Lee DH; Lee DK; Ahn HJ; Kim MM; Kim SJ; Morton RA
Oncogene; 2004 Oct; 23(46):7651-9. PubMed ID: 15354178
[TBL] [Abstract][Full Text] [Related]
5. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium.
Mathura JR; Jafari N; Chang JT; Hackett SF; Wahlin KJ; Della NG; Okamoto N; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):592-600. PubMed ID: 10670493
[TBL] [Abstract][Full Text] [Related]
7. mRNA expression of bone morphogenetic proteins and their receptors in human renal cell carcinoma.
Markić D; Ćelić T; Gršković A; Španjol J; Fučkar Ž; Grahovac B; Dorđević G; Bobinac D
Urol Int; 2011; 87(3):353-8. PubMed ID: 21876344
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues.
Wordinger RJ; Agarwal R; Talati M; Fuller J; Lambert W; Clark AF
Mol Vis; 2002 Jul; 8():241-50. PubMed ID: 12131877
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.
Yeh LC; Betchel KP; Lee JC
J Bone Miner Res; 1998 Dec; 13(12):1870-9. PubMed ID: 9844105
[TBL] [Abstract][Full Text] [Related]
10. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
Miyazaki H; Watabe T; Kitamura T; Miyazono K
Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
[TBL] [Abstract][Full Text] [Related]
11. Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.
Kim IY; Lee DH; Ahn HJ; Tokunaga H; Song W; Devereaux LM; Jin D; Sampath TK; Morton RA
Cancer Res; 2000 Jun; 60(11):2840-4. PubMed ID: 10850425
[TBL] [Abstract][Full Text] [Related]
12. Utilization of bone morphogenetic protein receptors during chondrocyte maturation.
Volk SW; D'Angelo M; Diefenderfer D; Leboy PS
J Bone Miner Res; 2000 Aug; 15(8):1630-9. PubMed ID: 10934663
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
14. Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation.
Nakamura Y; Wakitani S; Nakayama J; Wakabayashi S; Horiuchi H; Takaoka K
J Bone Miner Res; 2003 Oct; 18(10):1854-62. PubMed ID: 14584896
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
[TBL] [Abstract][Full Text] [Related]
16. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
Kumamoto H; Ooya K
Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer.
Schwalbe M; Sänger J; Eggers R; Naumann A; Schmidt A; Höffken K; Clement JH
Int J Oncol; 2003 Jul; 23(1):89-95. PubMed ID: 12792780
[TBL] [Abstract][Full Text] [Related]
18. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
[TBL] [Abstract][Full Text] [Related]
20. BMPs and BMPRs in chicken ovary and effects of BMP-4 and -7 on granulosa cell proliferation and progesterone production in vitro.
Onagbesan OM; Bruggeman V; Van As P; Tona K; Williams J; Decuypere E
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E973-83. PubMed ID: 12888485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
